Platelet‐activating factor increases mucosal permeability in rat intestine via tyrosine phosphorylation of E‐cadherin
Open Access
- 1 April 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 129 (7) , 1522-1529
- https://doi.org/10.1038/sj.bjp.0702939
Abstract
Platelet‐activating factor (PAF), an inflammatory mediator, plays an important role in mediating intestinal injury. However, it remains unclear whether PAF has a function in the intestine. The production of PAF by normal intestine and by unstimulated intestinal epithelial cell lines suggests that PAF may have a regulatory function in the normal bowel. In this study we investigated the role of PAF in modulating intestinal mucosal permeability in rats. Lumen‐to‐blood transit of FD‐4 (dextran 4400), (an index of intestinal permeability), was assessed in sham‐operated rats and rats injected with PAF (1.25 μg kg−1, i.v., a dose insufficient to induce intestinal injury). PAF‐induced villus cytoskeletal changes were examined by staining the intestine for F‐actin. The effect of PAF on tyrosine phosphorylation of the junctional protein E‐cadherin was examined by immunoprecipitation. Some rats were pretreated with AG1288 (a tyrosine kinase inhibitor) before PAF injection, and mucosal permeability change was assessed. To investigate the role of endogenous PAF upon mucosal permeability, we studied the effect of PAF antagonists on (intraluminal) glucose‐induced increase in mucosal permeability. We found that low dose PAF: (a) alters the cytoskeletal structure of intestinal epithelium, (b) causes the influx of FD4 from intestinal lumen to systemic circulation, (c) induces tyrosine phosphorylation of E‐cadherin and cadherin‐associated proteins. Glucose‐induced mucosal permeability increase is abolished by using two structurally different PAF antagonists. These results suggest that endogenous PAF modulates macromolecular movement across the intestinal mucosal barrier, probably via tyrosine phosphorylation of E‐cadherin and cytoskeletal alteration of enterocytes. British Journal of Pharmacology (2000) 129, 1522–1529; doi:10.1038/sj.bjp.0702939Keywords
This publication has 54 references indexed in Scilit:
- Interaction of platelet-activating factor, spleen and atrial natriuretic peptide in plasma volume regulation during endotoxaemia in ratsThe Journal of Physiology, 1998
- Intestinal NF-κB is activated, mainly as p50 homodimers, by platelet-activating factorBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998
- Protein Tyrosine Phosphorylation Modulates Microvessel Permeability in Frog MesenteryMicrocirculation, 1996
- The interaction between mast cells and nerves in the gastrointestinal tractImmunology Today, 1994
- PAF and TNF increase the precursor of NF-kappa B p50 mRNA in mouse intestine: quantitative analysis by competitive PCRBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Prevention of Lipopolysaccharide-Induced Lethal Toxicity by Tyrosine Kinase InhibitorsScience, 1994
- Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene.The Journal of cell biology, 1993
- Phospholipase C fromClostridium perfringensStimulates Formation and Release of Platelet-Activating Factor (PAF-Acether) in Cultured Intestinal Epithelial Cells (INT 407)Scandinavian Journal of Gastroenterology, 1991
- Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity.The Journal of cell biology, 1986
- Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-arc-1: mechanistic aspects and identification of the antigen as a component related to uvomorulin.The Journal of cell biology, 1985